Vaccines: correlates of vaccine-induced immunity
- PMID: 18558875
- DOI: 10.1086/589862
Vaccines: correlates of vaccine-induced immunity
Abstract
The immune system is redundant, and B and T cells collaborate. However, almost all current vaccines work through induction of antibodies in serum or on mucosa that block infection or interfere with microbial invasion of the bloodstream. To protect, antibodies must be functional in the sense of neutralization or opsonophagocytosis. Correlates of protection after vaccination are sometimes absolute quantities but often are relative, such that most infections are prevented at a particular level of response but some will occur above that level because of a large challenge dose or deficient host factors. There may be >1 correlate of protection for a disease, which we term "cocorrelates." Either effector or central memory may correlate with protection. Cell-mediated immunity also may operate as a correlate or cocorrelate of protection against disease, rather than against infection. In situations where the true correlate of protection is unknown or difficult to measure, surrogate tests (usually antibody measurements) must suffice as predictors of protection by vaccines. Examples of each circumstance are given.
Similar articles
-
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.Expert Rev Vaccines. 2004 Feb;3(1):23-34. doi: 10.1586/14760584.3.1.23. Expert Rev Vaccines. 2004. PMID: 14761241 Review.
-
A framework for assessing immunological correlates of protection in vaccine trials.J Infect Dis. 2007 Nov 1;196(9):1304-12. doi: 10.1086/522428. Epub 2007 Oct 2. J Infect Dis. 2007. PMID: 17922394
-
On immunity against infections and vaccines: credo 2004.Scand J Immunol. 2004 Jul-Aug;60(1-2):9-13. doi: 10.1111/j.0300-9475.2004.01460.x. Scand J Immunol. 2004. PMID: 15238068 Review.
-
Booster vaccinations: can immunologic memory outpace disease pathogenesis?Pediatrics. 2009 Dec;124(6):1633-41. doi: 10.1542/peds.2008-3645. Epub 2009 Nov 23. Pediatrics. 2009. PMID: 19933727 Review.
-
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.Nat Med. 2004 Aug;10(8):806-10. doi: 10.1038/nm0804-806. Nat Med. 2004. PMID: 15286782 Review.
Cited by
-
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.PLoS One. 2013;8(2):e55571. doi: 10.1371/journal.pone.0055571. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457473 Free PMC article. Clinical Trial.
-
Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease.Vaccines (Basel). 2023 Dec 25;12(1):24. doi: 10.3390/vaccines12010024. Vaccines (Basel). 2023. PMID: 38250837 Free PMC article.
-
Next-Generation Whole-Cell Pneumococcal Vaccine.Vaccines (Basel). 2019 Oct 16;7(4):151. doi: 10.3390/vaccines7040151. Vaccines (Basel). 2019. PMID: 31623286 Free PMC article. Review.
-
Few and far between: how HIV may be evading antibody avidity.PLoS Pathog. 2010 May 27;6(5):e1000908. doi: 10.1371/journal.ppat.1000908. PLoS Pathog. 2010. PMID: 20523901 Free PMC article. No abstract available.
-
Neutralization and beyond: Antibodies and HIV-1 acquisition.Curr Top Virol. 2018;15:73-86. Curr Top Virol. 2018. PMID: 31787808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical